立方制药(003020.SZ)2021年度净利润升27.47%至1.72亿元 拟10转3派7元

格隆汇4月18日丨立方制药(003020.SZ)发布2021年年度报告，实现营业收入22.73亿元，同比增长20.01%；归属于上市公司股东的净利润1.72亿元，同比增长27.47%；归属于上市公司股东的扣除非经常性损益的净利润1.52亿元，同比增长28.75%；基本每股收益1.86元，拟每10股派发现金红利7元(含税)，以资本公积金向全体股东每10股转增3股。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.